1. Home
  2. IMNN vs BTTC Comparison

IMNN vs BTTC Comparison

Compare IMNN & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$2.88

Market Cap

11.5M

Sector

Health Care

ML Signal

N/A

BTTC

Black Titan Corporation Ordinary Shares

N/A

Current Price

$1.37

Market Cap

13.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNN
BTTC
Founded
1982
1990
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
13.4M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
IMNN
BTTC
Price
$2.88
$1.37
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
37.7K
66.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.22
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$1.21
52 Week High
$9.32
$11.22

Technical Indicators

Market Signals
Indicator
IMNN
BTTC
Relative Strength Index (RSI) 39.79 42.06
Support Level $2.52 $1.23
Resistance Level $3.24 $1.57
Average True Range (ATR) 0.16 0.08
MACD -0.01 -0.00
Stochastic Oscillator 13.95 18.86

Price Performance

Historical Comparison
IMNN
BTTC

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About BTTC Black Titan Corporation Ordinary Shares

Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.

Share on Social Networks: